Among the clinical parameters analyzed in Col1a1-K18-hACE2 KI-infected mice, we found that the initial weight loss was similar to that of the K18-hACE mice but was not accompanied by the increased severity of clinical signs that characterize infection in these transgenic mice (neurological signs, lack of responsiveness, and poor general appearance) (13). This evidence concerns the gene COL1A1 and infection.